Physician profile
Asha Dua
NPI 1932165164
$968.74
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.20 · 2020: $80.57 · 2021: $332 · 2022: $139 · 2023: $201 · 2024: $65.52 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $319.78 | 2021-2023 | Shingrix |
| Abbott Laboratories | $167.54 | 2021 | |
| Horizon Therapeutics Plc | $103.63 | 2020-2021 | |
| Boston Scientific Corporation | $96.47 | 2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $90.83 | 2021-2024 | Gardasil 9, Gardasil, Vaxelis |
| Pfizer INC. | $68.28 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $35.09 | 2024-2025 | Zoryve |
| Cumberland Pharmaceuticals, INC. | $21.63 | 2023 | Kristalose |
| Ultragenyx Pharmaceutical INC. | $20.35 | 2021 | |
| Sobi, INC | $15.97 | 2021 | |
| Aytu Biopharma, INC. | $15.16 | 2025 | |
| Cranial Technologies, INC | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.